Sugi Predict

Sugi Predict / Compounds / SCHEMBL3441250

SCHEMBL3441250

SCHEMBL3441250

NC(C(=O)O)c1ccccc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ GABRA1 P14867 1/20 0.46
▸ GABRB2 P47870 1/20 0.46
▸ GRM1 Q13255 7/20 0.44
▸ KDM4E B2RXH2 6/20 0.43
▸ ALDH1A1 P00352 6/20 0.43
▸ HPGD P15428 6/20 0.43
▸ HSD17B10 Q99714 5/20 0.43
▸ TDP1 Q9NUW8 4/20 0.43
▸ GRM2 Q14416 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ TSHR P16473 2/20 0.42
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ HMGB1 P09429 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9420931 1.00 MEN1 (0.47) MEN1KMT2ACYP1A2CYP3A4GABRA1
SCHEMBL29672969 1.00 MEN1 (0.47) MEN1KMT2ACYP1A2CYP3A4GABRA1
SCHEMBL29672962 1.00 MEN1 (0.47) MEN1KMT2ACYP1A2CYP3A4GABRA1
SCHEMBL7886248 1.00 MEN1 (0.47) MEN1KMT2ACYP1A2CYP3A4GABRA1
SCHEMBL7887698 1.00 MEN1 (0.47) MEN1KMT2ACYP1A2CYP3A4GABRA1
SCHEMBL29419355 1.00 MEN1 (0.47) MEN1KMT2ACYP1A2CYP3A4GABRA1
Hydrochloric Acid SCHEMBL27551812 0.98 MEN1 (0.46) MEN1KMT2ACYP1A2CYP3A4GABRA1
SCHEMBL27557359 0.98 MEN1 (0.46) MEN1KMT2ACYP1A2CYP3A4GABRA1
Hydrochloric Acid SCHEMBL8615963 0.98 MEN1 (0.46) MEN1KMT2ACYP1A2CYP3A4GABRA1
Ethylene SCHEMBL8592522 0.96 MEN1 (0.44) MEN1KMT2ACYP1A2CYP3A4GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3374063-A1 FLUID FOR CARRYING OUT POLLUTION CONTROL IN HEAT ENGINES AND METHODS FOR PREPARING SAID FLUIDS BY PRODUCING A HOMOGENEOUS SOLUTION IFP Energies nouvelles (FR) 2018-09-19 — — EP claimed
CN-103295788-B Working electrolytic solution with high water-containing system for high-frequency low-impedance aluminum electrolytic capacitor and preparation method of working electrolytic solution 南通三鑫电子科技股份有限公司 2017-02-08 — — CN claimed
CN-103295788-A Working electrolytic solution with high water-containing system for high-frequency low-impedance aluminum electrolytic capacitor and preparation method of working electrolytic solution HAIMEN SANCON ELECTRONICS CO LTD 2013-09-11 — — CN claimed
EP-1817279-A2 17,20(Z)-DEHYDRO VITAMIN D ANALOGS AND THEIR USES WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2007-08-15 — — EP claimed
EP-1259215-B1 ANTI-MICROBIAL ANTIPERSPIRANT PRODUCTS UNILEVER PLC (GB) 2007-03-21 — — EP claimed
WO-2006057900-A2 17,20(Z)-DEHYDRO VITAMIN D ANALOGS AND THEIR USES WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2006-06-01 — — WO claimed
EP-1406581-A1 DEODORANT COMPOSITIONS COMPRISING A TRANSITION METAL CHELATOR AND A SILICON FLUID CARRIER UNILEVER PLC (GB) 2004-04-14 — — EP claimed
US-20030108499-A1 Deodorant compositions UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-06-12 — — US claimed
WO-2003007903-A1 DEODORANT COMPOSITIONS COMPRISING A TRANSITION METAL CHELATOR AND A SILICON FLUID CARRIER UNILEVER PLC (GB) 2003-01-30 — — WO claimed
EP-0818438-A1 CHIRAL DERIVATIVES OF HYDROXYPHENYLGLYCIN, AND THEIR USE IN THE SYNTHESIS OF PHARMACEUTICAL ACTIVE PRINCIPLES DERIVADOS DEL ETILO, S.A. (ES) 1998-01-14 — — EP claimed
US-4359093-A AQUEOUS SLUG OF ALKALINE MATERIAL AND A CHELATING AMINOPOLYCARBOXYLIC ACID OR SALT UNION OIL CO. OF CALIFORNIA (US) 1982-11-16 — — US claimed
US-4036300-A AMINOPOLYCARBOXYLIC ACIDS AND SALTS AS CHELATING AGENTS UNION OIL COMPANY OF CALIFORNIA (US) 1977-07-19 — — US claimed
US-20260092045-A1 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION 2026-04-02 — — US disclosed
US-20250275991-A1 ORAL COMPLEMENT FACTOR D INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION 2025-09-04 — — US disclosed
EP-4524133-A2 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2025-03-19 — — EP disclosed
EP-3939658-B1 SUBSTITUTED BENZOPYRROLE AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS BIOCRYST PHARM INC (US) 2024-10-02 — — EP disclosed
US-3993666-A Coumaranedione-3-monoximes BAYER AKTIENGESELLSCHAFT (DT) 1976-11-23 — — US disclosed
US-3993666-A Coumaranedione-3-monoximes BAYER AKTIENGESELLSCHAFT (DT) 1976-11-23 — — US disclosed
US-3880919-A Process for the production of alpha-amino-2-hydroxy-phenylacetic acids BAYER AG 1975-04-29 — — US disclosed
US-3880919-A Process for the production of alpha-amino-2-hydroxy-phenylacetic acids BAYER AG 1975-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250275991-A1 ORAL COMPLEMENT FACTOR D INHIBITORS CFD, CFH, CFB MEN1 659/4885KMT2A 4839/4885CYP1A2 2104/4885
US-20260092045-A1 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS TFPI, F3, BTK MEN1 1627/4885KMT2A 4136/4885CYP1A2 948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.